244 related articles for article (PubMed ID: 18328350)
1. Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults.
Aquilante CL; Kosmiski LA; Knutsen SD; Zineh I
Metabolism; 2008 Apr; 57(4):494-501. PubMed ID: 18328350
[TBL] [Abstract][Full Text] [Related]
2. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
Kim CS; Park HS; Kawada T; Kim JH; Lim D; Hubbard NE; Kwon BS; Erickson KL; Yu R
Int J Obes (Lond); 2006 Sep; 30(9):1347-55. PubMed ID: 16534530
[TBL] [Abstract][Full Text] [Related]
3. Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus.
Mojiminiyi OA; Abdella NA
Scand J Clin Lab Invest; 2007; 67(2):215-25. PubMed ID: 17366001
[TBL] [Abstract][Full Text] [Related]
4. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease.
Lee WL; Lee WJ; Chen YT; Liu TJ; Liang KW; Ting CT; Huey-Herng Sheu W
Metabolism; 2006 Aug; 55(8):1029-34. PubMed ID: 16839837
[TBL] [Abstract][Full Text] [Related]
5. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome.
Aso Y; Wakabayashi S; Nakano T; Yamamoto R; Takebayashi K; Inukai T
Metabolism; 2006 Aug; 55(8):1014-21. PubMed ID: 16839835
[TBL] [Abstract][Full Text] [Related]
6. Metabolic syndrome and high-sensitivity C-reactive protein in Cubans.
Huffman FG; Gomez GP; Zarini GG
Ethn Dis; 2009; 19(2):115-20. PubMed ID: 19537220
[TBL] [Abstract][Full Text] [Related]
7. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
[TBL] [Abstract][Full Text] [Related]
8. Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylarginine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome.
Wang TD; Chen WJ; Cheng WC; Lin JW; Chen MF; Lee YT
Am J Cardiol; 2006 Oct; 98(8):1057-62. PubMed ID: 17027571
[TBL] [Abstract][Full Text] [Related]
9. Effect of fenofibrate on adiponectin and inflammatory biomarkers in metabolic syndrome patients.
Rosenson RS
Obesity (Silver Spring); 2009 Mar; 17(3):504-9. PubMed ID: 19023279
[TBL] [Abstract][Full Text] [Related]
10. Resistin increases with obesity and atherosclerotic risk factors in patients with myocardial infarction.
Piestrzeniewicz K; Łuczak K; Komorowski J; Maciejewski M; Jankiewicz Wika J; Goch JH
Metabolism; 2008 Apr; 57(4):488-93. PubMed ID: 18328349
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease.
Youssef MY; Mojiminiyi OA; Abdella NA
Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368
[TBL] [Abstract][Full Text] [Related]
12. Resistin is an inflammatory marker of atherosclerosis in humans.
Reilly MP; Lehrke M; Wolfe ML; Rohatgi A; Lazar MA; Rader DJ
Circulation; 2005 Feb; 111(7):932-9. PubMed ID: 15710760
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and C-reactive protein among cardiology patients.
Chapidze G; Dolidze N; Enquobahrie DA; Kapanadze S; Latsabidze N; Williams MA
Arch Med Res; 2007 Oct; 38(7):783-8. PubMed ID: 17845899
[TBL] [Abstract][Full Text] [Related]
14. Association of white blood cell count with metabolic syndrome in patients undergoing peritoneal dialysis.
Park JT; Chang TI; Kim DK; Choi HY; Lee JE; Kim HW; Chang JH; Park SY; Kim E; Yoo TH; Han DS; Kang SW
Metabolism; 2009 Oct; 58(10):1379-85. PubMed ID: 19501862
[TBL] [Abstract][Full Text] [Related]
15. Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome.
Trøseid M; Lappegård KT; Claudi T; Damås JK; Mørkrid L; Brendberg R; Mollnes TE
Eur Heart J; 2004 Feb; 25(4):349-55. PubMed ID: 14984925
[TBL] [Abstract][Full Text] [Related]
16. Association between circulating monocyte chemoattractant protein-1 and urinary albumin excretion in nonobese Type 2 diabetic patients.
Takebayashi K; Matsumoto S; Aso Y; Inukai T
J Diabetes Complications; 2006; 20(2):98-104. PubMed ID: 16504838
[TBL] [Abstract][Full Text] [Related]
17. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
18. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
[TBL] [Abstract][Full Text] [Related]
19. High sensitivity C-reactive protein is associated with the metabolic syndrome independent to viral and bacterial pathogen burden.
Ebrahimi A; Nabipour I; Vahdat K; Jafari SM; Fouladvand M; Assadi M; Movahed A; Obeidi N; Sanjdideh Z
Diabetes Res Clin Pract; 2009 Jun; 84(3):296-302. PubMed ID: 19362745
[TBL] [Abstract][Full Text] [Related]
20. Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis.
Ellingsen T; Buus A; Stengaard-Pedersen K
J Rheumatol; 2001 Jan; 28(1):41-6. PubMed ID: 11196541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
